
Keywords: طرح مدیریت ریسک; AE; adverse event; AEFI; adverse event following immunisation; CDC; US Centers for Disease Control and Prevention; DNA; deoxyribonucleic acid; DTPa-IPV-HBV/Hib; combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-hepatitis b-Haemophilus